Off the back of successes such as Ozempic and Wegovy, GPCR-targeted drugs are a huge area of excitement for drug developers. Beyond metabolic diseases, GPCR targeted drugs are also being investigated for CNS, pain relief, oncology, and beyond. To keep up with the momentum, and the race to become first- and best-in-class, biopharma companies need help with in vitro pharmacology, discovery & screening, structural biology & characterization, biophysics, chemistry & hit-ID, and protein engineering & antibody services.

The 4th GPCRs-Targeted Drug Discovery Summit is the only GPCR dedicated forum designed to connect key stakeholders from across the US. With end-to-end coverage of the discovery, preclinical and clinical development of both small molecule and biologic GPCRs, the meeting will unite the sharpest minds working on GPCRs to share scientific learning and forge meaningful connections.

This is your outstanding opportunity to showcase your expertise and benchmark your brand as a key solutions provider and thought leader through our bespoke commercial packages.